Quarterly Results Archives

POWERINDIA – Hitachi Energy India – Q4 FY26 Financial Results – 25-May-26

Hitachi Energy India’s FY26 delivered 810 bps EBITDA margin expansion on scaling revenue, record ₹29,555 Cr backlog, and debt‑free balance sheet — a structural re‑rating story. Risks: WC intensity from receivables/inventory, geopolitical input costs, and execution on ballooning portfolio. Margin inflection with backlog momentum anchors compounding thesis.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 27.6% YoY (₹6,384.9 Cr → ₹8,147.7 Cr), driven by strong execution across grid, data centre, and export orders.
Q4FY26 revenue of ₹2,754 Cr surged 46.2% YoY vs Q4FY25’s ₹1,883.7 Cr — indicating an accelerating exit run-rate.
Order backlog of ₹29,555 Cr (3.6x FY26 revenue) provides multi-year revenue visibility.

Bottomline

PAT jumped 157.2% YoY (₹384 Cr → ₹987.8 Cr); excluding the ₹54.2 Cr exceptional Labour Codes charge, underlying PBT growth is even sharper at 178% (₹516.4 Cr → ₹1,375.2 Cr).
Q4FY26 PAT of ₹330.5 Cr grew 79.7% YoY vs Q4FY25’s ₹183.9 Cr — bottomline acceleration is outpacing topline.
EPS nearly tripled YoY: ₹90.4 → ₹221.6 (basic), on an unchanged share count of 4.46 Cr shares.

Margins

EBITDA (PBT before exceptional + D&A + Finance costs): FY26 = ₹1,375.2 + ₹104.3 + ₹12.8 = ₹1,492.3 Cr; EBITDA margin = 18.3% vs FY25’s (₹516.4 + ₹91.4 + ₹45.2) / ₹6,384.9 = 10.2%. A 810 bps expansion.
Net profit margin: 12.1% in FY26 vs 6.0% in FY25 — a 610 bps improvement, confirming operating leverage is kicking in at scale.
Other income of ₹239.9 Cr (vs ₹57.2 Cr prior year) — largely interest income on the large cash pile — contributed meaningfully; strip this out and core operating margin improvement is still substantial.

Growth Trajectory

Revenue CAGR implied over one year is 27.6%; with Q4 alone clocking ₹2,754 Cr, annualised exit rate is ~₹11,000 Cr — suggesting FY27 consensus could see significant upgrades.
Order intake of ₹18,456.5 Cr in FY26 is 2.3x FY26 revenue — book-to-bill well above 2x, sustaining the growth flywheel.
Exports at 36.8% of Q4 order intake and geographic diversification (US, Europe, APAC) reduce India-concentration risk.

TECHNOE – Techno Electric & Engineering Company – Q4 FY26 Financial Results – 25-May-26

Techno Electric’s FY26 delivered strong topline scaling but margin compression and negative OCF reflect mid‑cycle project execution. Near‑debt‑free balance sheet and ₹22,500 Mn liquidity cushion mitigate stress. Re‑rating hinges on margin inflection — collections, billing cycles, and EBITDA recovery toward 21–22% as projects near completion.

1–2 minutes

🔍 Observations

Topline

Revenue surged 43.3% YoY (₹22,687 Mn → ₹32,516 Mn), reflecting strong EPC order execution acceleration in H2FY26.
Q4FY26 revenue of ₹10,100 Mn grew 23.8% YoY and 15.8% QoQ — execution velocity clearly stepped up into year-end.
Other income declined to ₹1,495 Mn from ₹1,600 Mn as the investment portfolio was partially liquidated to fund working capital.

Bottomline

PAT from continuing operations rose 18.7% YoY (₹3,781 Mn → ₹4,487 Mn), but lagged revenue growth significantly — a margin compression story.
EPS grew only 9.5% YoY (₹37.19 → ₹40.74 on total operations), dampened by the absence of discontinued-ops contribution in FY26 vs FY25.
Q4FY26 PAT of ₹1,145 Mn fell 14.9% YoY vs Q4FY25’s ₹1,346 Mn — lower base quarter profitability despite higher revenues.

Margins

EBITDA margin contracted ~320 bps YoY: 22.0% (FY25) → 18.8% (FY26), as materials cost scaled faster than revenue.
PAT margin (continuing ops) compressed from 16.7% to 13.8% — cost of materials consumed rose to 78.7% of revenue vs 76.8% in FY25.
Finance costs jumped 82.9% (₹105 Mn → ₹193 Mn) as short-term borrowings were deployed to bridge working capital gaps.

Growth Trajectory

Revenue CAGR is strong, but profit growth is decelerating — PAT grew 18.7% on a 43.3% revenue base, signalling margin dilution risk if mix or pricing doesn’t improve.
Discontinued operations contributed ₹282 Mn in FY26 vs ₹448 Mn in FY25 — a structurally fading tailwind.
Order execution is clearly scaling; the question is whether margin recovery follows as projects mature.

RVNL – Rail Vikas Nigam – Q4 FY26 Financial Results – 25-May-26

RVNL’s FY26 shows earnings quality deterioration — topline flat, PAT down a third, and receivables surge turning cash‑generative EPC into cash consumer. Core railway pipeline intact, but re‑rating hinges on FY27 receivables recovery and margin inflection; until OCF turns positive, stock trades on order book narrative.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew a modest 2.5% YoY (₹19,923 Cr → ₹20,412 Cr), signalling execution pace rather than order-book constraints
Q4FY26 revenue of ₹6,696 Cr was the strongest quarter of the year, up 4.2% vs Q4FY25 — typical year-end project billings spike
Other income fell sharply 22.5% YoY (₹1,000 Cr → ₹775 Cr), dragging total income growth below operating revenue growth

Bottomline

Net profit collapsed 31.9% YoY (₹1,278 Cr → ₹871 Cr); EPS fell from ₹6.13 to ₹4.20
Q4FY26 PAT of ₹182 Cr was the weakest quarter — 60% below Q4FY25’s ₹455 Cr — a severe sequential and YoY deterioration
Tax rate improved marginally (22.4% vs 22.4% prior year), ruling out tax as the driver; the damage is entirely operational

Margins

Operating expense ratio (expense of operations / revenue from operations): FY26 = 92.8% vs FY25 = 92.5% — minimal worsening but leaves thin headroom
PBT margin compressed sharply: 5.8% in FY26 vs 8.3% in FY25 (₹1,181 Cr on ₹20,412 Cr revenue vs ₹1,646 Cr on ₹19,923 Cr)
Finance costs declined 23.1% YoY (₹545 Cr → ₹419 Cr) — the one material positive in the cost structure

Growth Trajectory

Revenue CAGR is decelerating; 2.5% topline growth on a government-capex-driven EPC business points to execution or award-conversion bottlenecks
Other income, which contributed ~5% of FY25 PBT, is structurally shrinking as cash balances are deployed or paid out as dividends
JV/associate profit share held flat at ~₹92–94 Cr — no meaningful delta from the equity investment portfolio

DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26

Divi’s FY26 delivered topline growth with rare margin expansion in APIs, funded capex doubling via accruals on debt‑free balance sheet. Risks: ₹718 Cr inventory build — demand vs procurement clarity due H1FY27. Strong OCF, accelerating exit rate, and expanding margins keep structural case intact despite FCF compression.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 12.8% YoY (₹9,360 Cr → ₹10,560 Cr), with Q4FY26 at ₹2,831 Cr — the strongest quarter of FY26, up 9.5% over Q4FY25’s ₹2,585 Cr.
Sequential revenue momentum held: Q2→Q3→Q4 progression of ₹2,604 Cr → ₹2,604 Cr → ₹2,831 Cr signals an accelerating exit rate into FY27.
Other income jumped 44% YoY (₹352 Cr → ₹507 Cr), driven by interest on FDs; operationally irrelevant but flatters total income.

Bottomline

Net profit grew 17.2% YoY (₹2,191 Cr → ₹2,568 Cr), outpacing revenue — positive operating leverage at work.
Q4FY26 PAT of ₹751 Cr was the highest quarterly print, up 13.4% over Q4FY25’s ₹662 Cr; sequential jump from ₹583 Cr reflects Q3’s one-time labour code charge of ₹74 Cr normalising out.
Basic EPS expanded from ₹82.53 to ₹96.75 — a 17.2% YoY improvement on an unchanged share count.

Margins

EBITDA (PBT ex-other income + depreciation + finance costs): FY26 = ₹3,462 – ₹507 + ₹463 + ₹23 = ₹3,441 Cr on revenue of ₹10,560 Cr → EBITDA margin 32.6% vs FY25: ₹2,916 – ₹352 + ₹402 + ₹2 = ₹2,968 Cr on ₹9,360 Cr → 31.7%. ~90 bps expansion YoY.
Net profit margin (PAT/Revenue from ops): FY26 = 2,568/10,560 = 24.3% vs FY25 = 2,191/9,360 = 23.4%. ~90 bps improvement.
Employee costs grew 16% YoY (₹1,243 Cr → ₹1,442 Cr) and material costs grew 14.6% (₹3,821 Cr → ₹4,378 Cr net of inventory change: ₹3,821–96 = ₹3,725 Cr FY25 vs ₹4,378–285 = ₹4,093 Cr FY26, +9.9%) — cost discipline preserved margin expansion.

Growth Trajectory

Revenue CAGR trajectory: 12.8% in FY26; combined with margin expansion, the earnings growth of 17.2% YoY demonstrates operating leverage materialising at scale.
CWIP nearly doubled (₹1,022 Cr → ₹2,113 Cr) and capex was ₹2,520 Cr in FY26 vs ₹1,438 Cr in FY25 — a 75% capex step-up signals management’s confidence in sustaining double-digit volume growth.
Total equity grew from ₹14,969 Cr to ₹16,761 Cr, entirely through retained earnings; the asset base expanded from ₹16,932 Cr to ₹20,033 Cr — 18.3% in one year.

PAGEIND – Page Industries – Q4 FY26 Financial Results – 21-May-26

Page Industries’ FY26 shows structurally sound balance sheet and premium franchise, but traded‑goods mix compresses margins and inventory build in sub‑7% growth year clouds demand visibility. Q4’s 14.1% revenue growth offers re‑rating path if FY27 sustains momentum and inventory normalises into cash flow.

1–2 minutes

🔍 Observations

Topline

FY26 revenue grew 6.3% YoY (₹4,93,491L → ₹5,24,678L), modest for a premium innerwear franchise but directionally intact.
Q4FY26 revenue jumped 14.1% YoY (₹1,09,807L → ₹1,25,260L), signalling a strong close to the year.
Traded goods purchases surged 56% YoY (₹73,771L → ₹1,15,161L), indicating a significant mix shift toward outsourced/traded inventory.

Bottomline

FY26 net profit grew 4.8% YoY (₹72,914L → ₹76,382L), lagging revenue growth — cost pressures compressed operating leverage.
Q4FY26 PAT of ₹17,873L grew 9.0% YoY (vs ₹16,401L), a cleaner quarter absent the Q3 exceptional charge.
EPS expanded from ₹653.71 to ₹684.81, a 4.8% YoY gain on flat share capital — purely earnings-driven.

Margins

FY26 EBITDA (PBT + Finance costs + D&A): ₹1,02,534L + ₹4,978L + ₹10,663L = ₹1,18,175L on revenue of ₹5,24,678L → EBITDA margin of 22.5% vs FY25: ₹97,858L + ₹4,638L + ₹9,923L = ₹1,12,419L on ₹4,93,491L → 22.8%. Marginal 30bps compression.
Net profit margin: FY26 = ₹76,382L / ₹5,24,678L = 14.6% vs FY25 = ₹72,914L / ₹4,93,491L = 14.8%. Stable but gently declining.
Employee costs rose 14.8% YoY (₹82,150L → ₹94,294L), growing materially faster than revenue — the primary margin drag.

Growth Trajectory

6.3% topline growth is below historical norms for Page Industries; the traded goods surge suggests channel/product mix changes rather than organic volume acceleration.
Q4 quarterly trend (14.1% YoY) is the strongest quarter of FY26 — momentum is improving into the new year.
Inventory build of ₹19,679L (cash flow basis) in a 6%-growth year is a caution flag on demand visibility.

HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26

Hindalco’s FY26 delivered ~10% pre‑exceptional earnings growth on 15% revenue jump, but debt rose ~56%, inventory ballooned 55%, and FCF turned negative amid capex bets. Novelis EBITDA/tonne recovery is the swing factor; FY26 is a transition year — watch Novelis margins, inventory normalization, and OCF recovery for re‑rating.

1–2 minutes

🔍 Observations

Topline

Consolidated revenue surged 15.3% YoY (₹2,38,496 Cr → ₹2,74,944 Cr), with Q4FY26 alone jumping 20.4% YoY (₹64,890 Cr → ₹78,133 Cr) — broadest quarterly run-rate in recent history.
Copper segment drove outsized topline contribution, growing 27.7% YoY (₹54,703 Cr → ₹69,838 Cr); Aluminium downstream accelerated 24.3% YoY (₹12,819 Cr → ₹15,938 Cr).
Novelis, the largest segment at 59% of revenue, grew a modest 12.3% YoY (₹1,45,068 Cr → ₹1,62,882 Cr) — volume/mix, not commodity tailwinds, likely driving it.

Bottomline

Reported PAT declined 16.3% YoY (₹16,002 Cr → ₹13,391 Cr), distorted entirely by exceptional charges of ₹6,963 Cr in FY26 vs. ₹879 Cr in FY25.
Pre-exceptional PBT grew 9.7% YoY (₹23,216 Cr → ₹25,459 Cr), confirming underlying earnings power is intact and expanding.
EPS (basic) compressed to ₹60.31 from ₹72.05 — optically weak, but exceptional-item-driven; core trajectory is positive.

Margins

Segment EBITDA expanded to ₹37,217 Cr from ₹35,162 Cr (+5.8% YoY); consolidated EBITDA (segment results + unallocable, pre-finance/D&A) at ₹38,097 Cr vs. ₹35,496 Cr (+7.3% YoY).
EBITDA margin on revenue from operations: 38,097 / 2,74,944 = 13.9% vs. 35,496 / 2,38,496 = 14.9% — 100 bps compression YoY, partly attributable to Copper’s lower-margin revenue mix growing fastest.
Aluminium upstream segment result improved to ₹18,884 Cr from ₹16,262 Cr (+16.1% YoY) — the highest-margin segment delivering the best absolute growth.

Growth Trajectory

Revenue CAGR implied over two years is healthy, but working capital consumption is accelerating disproportionately — a structural flag for FY27 free cash flow visibility.
Aluminium downstream, though small, grew 54.5% in segment results (₹633 Cr → ₹978 Cr) — early signs of downstream value-add monetisation.
Novelis segment result fell 4.6% YoY (₹15,242 Cr → ₹14,546 Cr) despite revenue growth — margin dilution at the most important subsidiary warrants monitoring.

EICHERMOT – Eicher Motors – Q4 FY26 Financial Results – 22-May-26

Eicher Motors’ FY26 delivered 24% revenue growth, ₹3,530 Cr FCF, near‑zero leverage, and VECV JV momentum. Risks: 150 bps PAT margin compression and Q4 revenue stall. Re‑rating now hinges on margin leverage from new platforms and global scale‑up; treasury earnings floor strong but RE must grow without dilution.

1–2 minutes

🔍 Observations

Topline

Revenue from operations crossed ₹23,408 Cr in FY26 vs ₹18,870 Cr in FY25 — 24.0% YoY growth, driven by Royal Enfield volume expansion and premiumisation
Q4FY26 revenue at ₹6,080 Cr vs ₹5,241 Cr in Q4FY25 — 16.0% YoY growth; sequentially flat vs Q3FY26 (₹6,114 Cr)
Other income (investment returns) rose to ₹1,487 Cr in FY26 from ₹1,305 Cr — meaningful contributor given the large treasury corpus

Bottomline

PAT grew 16.5% YoY to ₹5,515 Cr (FY26) from ₹4,734 Cr (FY25); Q4FY26 PAT at ₹1,520 Cr, up 11.6% vs Q4FY25 (₹1,362 Cr)
JV profit contribution (VECV) rose to ₹798 Cr in FY26 from ₹700 Cr — 14.0% YoY; Q4FY26 VECV share surged to ₹323 Cr vs ₹248 Cr in Q4FY25
Basic EPS expanded to ₹201.09 in FY26 from ₹172.76 in FY25 — 16.4% YoY growth

Margins

FY26 EBITDA (PBT before JV + D&A + Finance costs): ₹6,359.70 + ₹840.37 + ₹71.53 = ₹7,271.60 Cr on revenue of ₹23,408 Cr → EBITDA margin ~31.1% vs ~30.7% in FY25 (₹5,233.26 + ₹729.33 + ₹54.34 = ₹6,016.93 Cr / ₹18,870 Cr) — marginal expansion
Net profit margin (PAT / Revenue from ops): 5,515 / 23,408 = 23.6% vs 4,734 / 18,870 = 25.1% in FY25 — 150bps compression, partly from higher tax (effective rate rose from 20.2% to 22.3%)
Raw material + traded goods as % of revenue: (12,502 + 835 − 270) / 23,408 = 55.4% vs (9,953 + 507 − 164) / 18,870 = 54.8% — modest input cost inflation absorbed

Growth Trajectory

Revenue CAGR at 24% for FY26 points to strong demand; sequential flatness in Q4 warrants watching for volume plateau
PAT growth (16.5%) lagging revenue growth (24.0%) signals operating leverage not fully flowing through — cost base scaling faster than topline
VECV’s improving profit trajectory (14% YoY) adds earnings resilience via non-motorcycle diversification

SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Financial Results – 22-May-26

Sun Pharma’s FY26 delivered 11% topline growth with ~31.5% EBITDA margins, specialty pivot sustaining quality. PAT up 5% understates strength; underlying trajectory solid. Re‑rating hinges on specialty‑led margin inflection toward 34–35%. Risks: faster opex growth, acquisition integration, intangibles spike, and receivables build.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 11.2% YoY (₹525,784 Mn → ₹584,620 Mn), driven by both domestic formulations and specialty/global generic expansion.
Q4FY26 revenue of ₹146,118 Mn grew 12.8% YoY vs Q4FY25 (₹129,588 Mn), though declined 5.9% QoQ from Q3FY26’s ₹155,205 Mn — seasonal softness, not structural.
Other operating revenues fell sharply (₹5,372 Mn → ₹2,419 Mn YoY), a ₹2,953 Mn headwind to topline largely absorbed by core revenue momentum.

Bottomline

Reported PAT grew 5.0% YoY (₹109,290 Mn → ₹114,794 Mn); adjusted for ₹13,075 Mn of exceptional items in FY26 vs ₹6,779 Mn in FY25, underlying PAT growth is broadly similar.
Tax outflow surged — effective tax rate on reported PBT rose from ~17.4% to ~26.0% — compressing PAT despite strong EBIT growth; a large one-off deferred tax reversal benefited FY25.
EPS grew modestly from ₹45.6 to ₹47.8 (basic), with no dilution — share count flat at ~2,399 Mn shares.

Margins

EBITDA (PBT before exceptional + Finance costs + D&A): FY26 = ₹151,189 + ₹3,389 + ₹29,379 = ₹183,957 Mn on revenue of ₹584,620 Mn → EBITDA margin ~31.5% vs FY25: ₹137,521 + ₹2,314 + ₹25,754 = ₹165,589 Mn on ₹525,784 Mn → 31.5%. Margins held flat despite R&D intensity rising.
Net profit margin: ₹114,794 / ₹584,620 = 19.6% vs ₹109,290 / ₹525,784 = 20.8% — 120 bps compression, driven entirely by tax normalisation.
R&D spend rose to ₹34,741 Mn (5.9% of revenue) vs ₹31,542 Mn (6.0%) — pipeline investment sustained without margin sacrifice.

Growth Trajectory

Three-year revenue compound implied by 11.2% topline growth and consistent specialty mix shift signals durable mid-teens USD revenue CAGR in global markets.
Employee costs grew 14.5% YoY (₹99,731 Mn → ₹114,189 Mn), outpacing revenue — talent investment for specialty scaling, but warrants monitoring.
Other expenses grew 13.3% YoY (₹167,718 Mn → ₹190,083 Mn) — faster than revenue, suggesting operating leverage yet to fully materialise.

TORNTPHARMA – Torrent Pharmaceuticals – Q4 FY26 Financial Results – 22-May-26

Torrent Pharma’s FY26 vaulted revenues past ₹13,900 Cr via acquisition, but net debt/EBITDA ~2.9x and ₹24,280 Cr intangibles suppress PAT. Core remains resilient with ₹2,346 Cr FCF and ~31% EBITDA margins. Re‑rating hinges on brand revenue scaling faster than amortisation; watch receivables and finance costs.

1–2 minutes

🔍 Observations

Topline

Revenue from ops grew 21.4% YoY (₹11,516 Cr → ₹13,980 Cr), reflecting the step-up from an acquired business consolidating into FY26 numbers.
Q4FY26 printed ₹4,197 Cr — +41.8% YoY and +27.1% QoQ — the sharpest quarterly outturn, indicating the full consolidation effect landed in Q4.
Other income turned negative in FY26 (–₹94 Cr vs +₹23 Cr), reflecting forex and hedging losses that clipped reported total income.

Bottomline

Net profit grew 11.9% YoY (₹1,911 Cr → ₹2,138 Cr), well below revenue growth — margin dilution from acquisition-linked D&A and finance costs.
Q4FY26 net profit collapsed to ₹364 Cr vs ₹498 Cr in Q4FY25 (–26.9% YoY), driven by ₹236 Cr finance costs, ₹508 Cr D&A, and ₹66 Cr exceptional charges in a single quarter.
Effective tax rate improved to 25.6% (from 28.5%), providing partial offset; without this, PAT growth would have been thinner still.

Margins

EBITDA margin contracted ~100 bps to 31.3% (FY26) from 32.3% (FY25) — operating leverage partly absorbed by employee cost growth of 21.2% YoY.
Net profit margin compressed 130 bps to 15.3%, squeezed by D&A surging 40.8% and finance costs up 52.8%.
Q4FY26 EBITDA margin held at 31.9% (vs 32.0% in Q4FY25) — the operational core is stable; below-EBITDA lines are where the dilution originates.

Growth Trajectory

Organic revenue growth is likely sub-15%; the headline 21.4% is acquisition-inflated — normalisation will depend on how fast the acquired portfolio integrates.
EPS grew 13.2% (₹56.47 → ₹63.92) despite no equity dilution — share count unchanged at 169.23 Cr shares — all growth is earnings-driven on the legacy base.
D&A will remain elevated for multiple years as ₹24,280 Cr of intangible assets amortise; this is the single biggest structural drag on reported PAT growth.

PRESTIGE – Prestige Estates Projects – Q4 FY26 Financial Results – 21-May-26

1–2 minutes

🔍 Observations

Topline

Revenue surged 72.6% YoY (₹73,494 Mn → ₹126,854 Mn), with Q4FY26 alone delivering 166.5% YoY growth (₹15,284 Mn → ₹40,738 Mn) — the strongest quarter on record.
Sequential momentum held: Q4FY26 revenue grew 5.2% over Q3FY26 (₹38,726 Mn), signaling consistent delivery throughput rather than a one-quarter flush.
Revenue scale now reflects accelerated project completions and handovers, typical of Prestige’s POC-revenue recognition model.

Bottomline

PAT more than doubled YoY (₹6,169 Mn → ₹13,054 Mn, +111.6%), with Q4FY26 PAT of ₹2,918 Mn against ₹431 Mn in Q4FY25 — a 577% YoY jump driven by operating leverage and deferred tax reversals.
EPS expanded 148% YoY (₹11.19 → ₹27.76), compounding the effect of the FY25 QIP dilution now being earnings-accretive.
Tax efficiency aided FY26 PAT: effective tax rate was 23.8% (₹4,082 Mn on ₹17,136 Mn PBT), supported by ₹4,818 Mn deferred tax credit.

Margins

EBITDA margin compressed 640 bps YoY (39.5% → 33.1%) despite absolute EBITDA growing 44.8% (₹29,019 Mn → ₹42,021 Mn) — scale comes at a margin cost as lower-margin projects are completed.
Q4FY26 EBITDA margin contracted sharply to 26.5% vs 38.6% in Q4FY25, pointing to higher land costs (₹14,808 Mn in Q4 alone) and contractor cost dilution in the quarter’s mix.
Net margin improved 190 bps (8.4% → 10.3%), as finance cost leverage and deferred tax benefits more than offset operating margin dilution.

Growth Trajectory

Revenue CAGR implied over FY25–26 is 72.6% — unsustainably rapid, but reflects a genuine step-change in delivery scale, not accounting optionality.
Inventory on the balance sheet grew 26.3% (₹318,831 Mn → ₹402,519 Mn) alongside customer advances growing 31.3% (₹250,732 Mn → ₹329,438 Mn) — pipeline is robust and pre-sold.
Finance costs grew 18.6% YoY (₹13,338 Mn → ₹15,824 Mn), slower than revenue growth — a structural positive as leverage cost is being absorbed into expanding revenue.